C. Almenglo

Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value

J. González-Juanatey, C. Almenglo, M. Couselo-Seijas, 2021, Journal of Molecular Medicine.

Edoxaban's contribution to key endothelial cell functions.

J. González-Juanatey, C. Almenglo, M. González-Peteiro, 2020, Biochemical pharmacology.

The Effect of Mineralocorticoid Receptor 3 Antagonists on Anti-Inflammatory and Anti-Fatty Acid Transport Profile in Patients with Heart Failure

J. González-Juanatey, C. Almenglo, S. Eiras, 2022, Cells.

Higher ACE2 expression levels in epicardial cells than subcutaneous stromal cells from patients with cardiovascular disease: Diabetes and obesity as possible enhancer

J. González-Juanatey, C. Almenglo, M. Couselo-Seijas, 2020, European journal of clinical investigation.

Synergism between obesity and HFpEF on neutrophils phenotype and its regulation by adipose tissue‐molecules and SGLT2i dapagliflozin

J. González-Juanatey, M. Flores-Arias, C. Almenglo, 2022, Journal of cellular and molecular medicine.